BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23262140)

  • 1. Site-specifically 11C-labeled Sel-tagged annexin A5 and a size-matched control for dynamic in vivo PET imaging of protein distribution in tissues prior to and after induced cell death.
    Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Linder S; Arnér ES; Stone-Elander S
    Biochim Biophys Acta; 2013 Mar; 1830(3):2562-73. PubMed ID: 23262140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining [11C]-AnxA5 PET imaging with serum biomarkers for improved detection in live mice of modest cell death in human solid tumor xenografts.
    Cheng Q; Lu L; Grafström J; Olofsson MH; Thorell JO; Samén E; Johansson K; Ahlzén HS; Stone-Elander S; Linder S; Arnér ES;
    PLoS One; 2012; 7(8):e42151. PubMed ID: 22870292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo comparison of 18F and 123I-labeled ML10 with 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis.
    Bauwens M; De Saint-Hubert M; Cleynhens J; Vandeputte C; Li J; Devos E
    Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):187-200. PubMed ID: 23389693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural requirements for in vivo detection of cell death with 99mTc-annexin V.
    Tait JF; Smith C; Blankenberg FG
    J Nucl Med; 2005 May; 46(5):807-15. PubMed ID: 15872355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis.
    Bauwens M; De Saint-Hubert M; Devos E; Deckers N; Reutelingsperger C; Mortelmans L; Himmelreich U; Mottaghy FM; Verbruggen A
    Nucl Med Biol; 2011 Apr; 38(3):381-92. PubMed ID: 21492787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of methods for evaluating radiolabelled Annexin A5 uptake in pre-clinical PET oncological studies.
    Grafström J; Stone-Elander S
    Nucl Med Biol; 2014; 41(10):793-800. PubMed ID: 25156038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods.
    Tait JF; Smith C; Levashova Z; Patel B; Blankenberg FG; Vanderheyden JL
    J Nucl Med; 2006 Sep; 47(9):1546-53. PubMed ID: 16954565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER2-positive tumors imaged within 1 hour using a site-specifically 11C-labeled Sel-tagged affibody molecule.
    Wållberg H; Grafström J; Cheng Q; Lu L; Martinsson Ahlzén HS; Samén E; Thorell JO; Johansson K; Dunås F; Olofsson MH; Stone-Elander S; Arnér ES; Ståhl S
    J Nucl Med; 2012 Sep; 53(9):1446-53. PubMed ID: 22872744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET.
    Dekker B; Keen H; Lyons S; Disley L; Hastings D; Reader A; Ottewell P; Watson A; Zweit J
    Nucl Med Biol; 2005 Apr; 32(3):241-52. PubMed ID: 15820759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
    Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
    J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of a radiolabeled bis-zinc(II)-cyclen complex as a potential probe for in vivo imaging of cell death.
    Wang H; Wu Z; Li S; Hu K; Tang G
    Apoptosis; 2017 Apr; 22(4):585-595. PubMed ID: 28084570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past, present, and future of annexin A5: from protein discovery to clinical applications.
    Boersma HH; Kietselaer BL; Stolk LM; Bennaghmouch A; Hofstra L; Narula J; Heidendal GA; Reutelingsperger CP
    J Nucl Med; 2005 Dec; 46(12):2035-50. PubMed ID: 16330568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
    Yagle KJ; Eary JF; Tait JF; Grierson JR; Link JM; Lewellen B; Gibson DF; Krohn KA
    J Nucl Med; 2005 Apr; 46(4):658-66. PubMed ID: 15809489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 99mTc-labeled annexin V fragments: a potential SPECT radiopharmaceutical for imaging cell death.
    Mukherjee A; Kothari K; Tóth G; Szemenyei E; Sarma HD; Környei J; Venkatesh M
    Nucl Med Biol; 2006 Jul; 33(5):635-43. PubMed ID: 16843838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between human pharmacokinetics and imaging properties of two conjugation methods for 99mTc-annexin A5.
    Boersma HH; Liem IH; Kemerink GJ; Thimister PW; Hofstra L; Stolk LM; van Heerde WL; Pakbiers MT; Janssen D; Beysens AJ; Reutelingsperger CP; Heidendal GA
    Br J Radiol; 2003 Aug; 76(908):553-60. PubMed ID: 12893698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-Labeled wild-type annexin V: comparison of random and site-selective radiolabeling methods.
    Perreault A; Knight JC; Wang M; Way J; Wuest F
    Amino Acids; 2016 Jan; 48(1):65-74. PubMed ID: 26255286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging apoptosis in vivo using 124I-annexin V and PET.
    Keen HG; Dekker BA; Disley L; Hastings D; Lyons S; Reader AJ; Ottewell P; Watson A; Zweit J
    Nucl Med Biol; 2005 May; 32(4):395-402. PubMed ID: 15878509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells.
    Vangestel C; Peeters M; Oltenfreiter R; D'Asseler Y; Staelens S; Van Steenkiste M; Philippé J; Kusters D; Reutelingsperger C; Van Damme N; Van de Wiele C
    Nucl Med Biol; 2010 Nov; 37(8):965-75. PubMed ID: 21055628
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.